Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BALOXAVIR MARBOXIL vs FOSCARNET: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BALOXAVIR MARBOXIL vs FOSCARNET: Safety Overview

Metric BALOXAVIR MARBOXIL FOSCARNET
Total FAERS Reports 2,010 2,057
Deaths Reported 120 605
Death Rate 6.0% 29.4%
Hospitalizations 378 608
Average Patient Age 37.8 yrs 41.8 yrs
% Female Patients 53.8% 40.6%
FDA Approval Date Mar 18, 2021 Apr 21, 2021
Manufacturer Genentech, Inc. Hikma Pharmaceuticals USA Inc.
Route ORAL INTRAVENOUS
Marketing Status Discontinued Prescription